Pfizer Inc. is vulnerable to the possibility that President Donald Trump will place tariffs on the European Union, where the ...
Albert Bourla, Pfizer CEO, joins CNBC's Angelica Peebles and 'Closing Bell Overtime' to talk the impact of tariffs, Pfizer's drug pipeline, vaccines and more.
The pharmaceutical industry’s biggest lobbying group is scheduled to meet with President Donald Trump on Thursday, according ...
As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives ...
Director nominees with CEO experience have long featured in Board slates put forward by activist investors. Those candidates were typically from outs ...
Pfizer faces revenue decline from patent expirations, profitability challenges, and bearish technicals. Learn why PFE stock ...
Activist investor Starboard Value has launched a broadside against Pfizer's leadership under chief executive Albert Bourla ... such as the removal of Bourla as CEO, or make any recommendations ...
Last week Pfizer announced that Ian Read is to step down as CEO, with chief operating officer Albert Bourla taking the helm. Following the change of leadership, Pfizer is also revamping its ...
Vaccine policy, Medicare drug negotiations, and a potential DTC advertising ban will all fall under Kennedy’s purview as HHS Secretary.
Some, like Pfizer Inc. Chief Executive Officer Albert Bourla, were in Washington for the inauguration weekend. And within the corporate ranks, there was optimism that the new administration would ...
Amazon CEO Andy Jassy sent a message to employees saying he was "incredibly relieved" that Alexander (Sasha) Troufanov was released from Hamas captivity after being held hostage for nearly 500 days.
Vertiv CEO Giordano Albertazzi joins Market Domination with Julie Hyman and Josh Lipton to discuss the state of the artificial intelligence (AI) market after Chinese AI start-up DeepSeek raised ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results